Non-Small Cell Lung Cancer (NSCLC)

DBCOND0034130NeoplasmsRespiratory Tract Diseases

Non-Small Cell Lung Cancer (NSCLC) is the indication for 7 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
NSCLC · Non-small Cell Lung Cancers · Lung Cancer (NSCLC) · Lung Cancer (Non-Small Cell) · NSCLC (Non-Small Cell Lung Cancer)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT768830SNOMED CT254637007MedDRA10029514UMLSC0007131

What you can answer from here — as of October 22, 2026

7Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
3,711Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Non-Small Cell Lung Cancer (NSCLC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In